Obesity is excessive accumulation of adipose tissue within the body, which exceeds the body's skeletal and physical standards. Obesity is now recognized as a serious chronic disease, which not only affects your health but your day-to-day living. When the calories intake exceeds the actual amount of calories needed for an individual's daily activity, the excessive calories are stored in the body as fat. Eventually this fat deposition increases and leads to excess weight accumulation. Food intake, daily physical activity, living habits and at times genes largely affect being obese.



Obesity is a very dangerous condition that can even lead to death, therefore an obesity treatment becomes necessary. You can find more about Acomplia, an anti-obesity medication.

About Acomplia

Acomplia is an obesity control pill, which is manufactured by Sanofi Aventis ? a Paris based leading pharmaceutical giant. For the obese, Acomplia is a boon which acts as a weight loss pill; keeps a check on the fat deposition and helps them to get in shape.

Controversies when Acomplia was introduced

Acomplia is successfully approved to use within the European Union (EU) and is readily available for medical use since June 2006. However, this drug is yet not available in the UK's National Health Service (NHS) and therefore it is available only on private prescription. FDA approval is still in process therefore it is not available for medical use in the United States. However, it will be introduced as Zimulti in the United States.

The safety and the pending approval in United States have given birth to lots of controversies surrounding Acomplia.

Medical tests on Acomplia and its success rates

During the clinical trials that were held over one year, 33% of patients lost more than 10% of their initial body weight. About two thirds of patients lost over 5% of their body weight. All these patients were kept on a calorie-controlled diet during the trial periods. The patients who consumed Acomplia to lose weight have not regained the weight. However, no data is produced to support this claim. Nevertheless, a controlled diet, and an active life style may help to retain the lost weight.

Comes in the strength of

Acomplia is available in the form of tablet with strength of 20mg. It is an oral prescription drug, which is to be taken once in a day, before breakfast.

Ingredients of Acomplia

Acomplia contains a new class of active chemical ingredient called rimonabant, which acts by selectively blocking CB1 receptors in the brain and in peripheral organs important in glucose and lipid (or fat) metabolism.

CB1 receptor obstruction with Acomplia acts to decrease the over activity of the endocannabinoid system also known as EC system. This system is characterized physiological system that includes CB1 receptors and it has been shown to play an important role in regulating the body weight. It not only controls the energy balance but also the glucose and fat metabolism.

Side effects of Acomplia

It is a well know fact that all drugs have some or the other side effects. So does Acomplia. The patients may experience psychiatric disorders such as depression, anxiety and irritability. Nervous system disorders such as headache or dizziness and gastrointestinal disorders such as nausea vomiting may be experienced.

Normally, these side effects settle down once the regular doses of Acomplia are consumed. However, as a word of caution, all the side effects whatsoever should be immediately brought to the notice of your doctor.

Online availability of Acomplia

Acomplia is available online at many internet based pharmaceutical sources. If you wish to get Acomplia online, make sure you buy it from a safe and reputed online source.

How Acomplia is safe and best weight loss drug?

Acomplia is one of the most awaited anti-obesity therapeutics for the time. It is an appetite suppressant, which starts affecting within 2 weeks of consumption. Studies and clinical trials show that as much as 10% of total weight loss is seen within a year with little side effects. Acomplia has already paved its way into the European market which itself is an indication of its being safe and top-of-the-line anti-obesity drug.